Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcf.2020.04.012 http://scihub22266oqcxt.onion/10.1016/j.jcf.2020.04.012 32376098!7183287!32376098     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Cyst+Fibros 2020 ; 19 (3): 355-358 Nephropedia Template TP {{tp|p=32376098|t=2020. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis |pdf=|usr=}}{{32376098}} gab.com Text A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis JO: J Cyst Fibros http://www.kidney.de/pget.php?&tw=1&pmid=32376098 #FOAvip Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic fibrosis. METHODS: Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised. RESULTS: 40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted. CONCLUSIONS: This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection. Twit Text FOAVip A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis ????J Cyst Fibros http://www.kidney.de/pget.php?&tw=1&pmid=32376098 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32376098 #FOAvip English Wikipedia <ref>{{Cite pmid|32376098}}</ref> A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis #MMPMID32376098 Cosgriff R; Ahern S; Bell SC; Brownlee K; Burgel PR; Byrnes C; Corvol H; Cheng SY; Elbert A; Faro A; Goss CH; Gulmans V; Marshall BC; McKone E; Middleton PG; Ruseckaite R; Stephenson AL; Carr SB J Cyst Fibros 2020[May]; 19 (3): 355-358 PMID32376098show ga Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic fibrosis. METHODS: Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised. RESULTS: 40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted. CONCLUSIONS: This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection. |*Betacoronavirus[MESH] |Adolescent[MESH] |Adult[MESH] |Australia[MESH] |COVID-19[MESH] |Canada[MESH] |Coronavirus Infections/complications/*diagnosis/*therapy[MESH] |Cystic Fibrosis/complications/therapy/*virology[MESH] |Europe[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |New Zealand[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*diagnosis/*therapy[MESH] |SARS-CoV-2[MESH] |Symptom Assessment[MESH] |United States[MESH]A multinational report to characterise SARS-CoV-2 infection in people (epmc).pdf DeepDyve Pubget Overpricing